title: Survey among members of the roman group of gynecologic endoscopy on the use of agents for postoperative adhesion prevention.
abstract: OBJECTIVE
  To evaluate patterns of use of agents for postoperative adhesion prevention.
  
  
  METHODS
  Mail survey.
  
  
  METHODS
  Departments of Obstetrics and Gynecology, university-affiliated and public hospitals, Rome, Italy.
  
  
  METHODS
  Members of the Roman Group of Gynecologic Endoscopy.
  
  
  METHODS
  Evaluation of forms returned.
  
  
  RESULTS
  The response rate to either electronic or regular mailing was 31%, for a total of 42 forms evaluated. For laparoscopy, the perceived postoperative de novo adhesion formation rate was 0%-25%, whereas the adhesion reformation rate was 26%-75%; for laparotomy, the rates were 26%-75% and >75%, respectively. Sixty-five percent of the respondents were using at least one method for postoperative adhesion prevention during laparoscopy, and 68% during laparotomy. The most frequently used method during laparoscopy was Ringer's lactate (77% of the respondents), followed by ferric hyaluronate gel (46% of the respondents), and 4% icodextrin (39% of respondents). During laparotomy, the most frequently used methods were Ringer's lactate (28%), normal saline (20%), and 4% icodextrin (20%). Antibiotic prophylaxis was used by 87.5% of respondents.
  
  
  CONCLUSIONS
  Postoperative adhesion formation, and especially reformation, are perceived as significant problems. Sixty-five percent of the respondents used some method for adhesion prevention after operative laparoscopy, with Ringer's lactate, ferric hyaluronate gel, and 4% icodextrin being the most frequently used.
authors.affiliation: Department of Gynecology and Obstetrics, Università Campus Bio-Medico, Rome, Italy.
authors.forename: Ludovico
authors.initials: L
authors.lastname: Muzii
mesh_terms: D005290:Ferric Compounds / Q000627:therapeutic use*; D013509:Gynecologic Surgical Procedures / Q000009:adverse effects / Q000379:methods; D019538:Health Care Surveys; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D007558:Italy; D010535:Laparoscopy / Q000009:adverse effects* / Q000379:methods; D011183:Postoperative Complications / Q000517:prevention & control; D010818:Practice Patterns, Physicians'; D018570:Risk Assessment; D012955:Societies, Medical; D011795:Surveys and Questionnaires; D000267:Tissue Adhesions / Q000209:etiology / Q000517:prevention & control*
chemical_list: D005290:Ferric Compounds; D006820:Hyaluronic Acid